Celgene Corp (NASDAQ:CELG)

CAPS Rating: 5 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Caps

How do you think CELG will perform against the market?

Add Stock to CAPS Watchlist

All Players

2,313 Outperform
77 Underperform
 

All-Star Players

457 Outperform
13 Underperform
 

Wall Street

28 Outperform
1 Underperform
 

Top CELG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFPencils (99.86)
Submitted May 21, 2018

Taking a bit of a flyer on this one given the leadership shuffling going on and questions surrounding some drugs in its pipeline. But despite the near-term challenges, Celgene is still producing more than $3.7 billion in FCF annually and is now… More

NetscribeBiotech (97.13)
Submitted February 22, 2007

Celgene is a biopharmaceutical company focused on novel therapies to treat a broad range of hematopoietic, immunological, neuronal, and cancerous conditions. Celgene currently markets Thalomid for ENL and multiple myeloma, Revlimid for… More

CELG VS S&P 500 (SPY)

Fools bullish on CELG are also bullish on:

Fools bearish on CELG are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CELG.

Recs

0
Member Avatar tiomiguel (40.96) Submitted: 12/3/2018 6:54:58 PM : Outperform Start Price: $73.53 CELG Score: -0.38

Strong historical sales growth, expectations of strong future earnings growth, a low PEG ratio, positive free cash flow and favorable margins compared to industry.

Recently singled out by Morningstar as one of their "Stocks for the Next Decade" (narrow moat, positive "moat trend," 5-star rating [indicating current price way below their fair value estimate]).

Recs

0
Member Avatar future21 (59.47) Submitted: 11/7/2018 10:26:39 PM : Outperform Start Price: $75.17 CELG Score: -1.84

Strong pipeline, been watching this stock for a few years and like the recent discount. Seems like a great opportunity to buy a strong player in healthcare. I worry about the political rhetoric surrounding healthcare profits as a long-term headwind, and will watch closely to see how that might affect Celgene in the years to come. In general, healthcare is an ever-present industry and a strong pipeline, history of success, and revenue to support future research makes this a less risky pick than many of the other options. TMF's recent report on catalysts for short-term growth is also encouraging, but I'm looking for a long run based on the pipeline.

Will watch the political climate and the FDA approval process for the potential blockbusters in Celgene's pipeline as possible red flags.

Recs

0
Member Avatar tsunamied (66.93) Submitted: 11/2/2018 12:30:38 AM : Outperform Start Price: $76.21 CELG Score: -4.95

BIOTECH. CRISPR. YEAH!

Leaderboard

Find the members with the highest scoring picks in CELG.

Score Leader

InvestorDeb

InvestorDeb (71.05) Score: +432.42

The Score Leader is the player with the highest score across all their picks in CELG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
martyc484 < 20 9/15/2006 Outperform 3Y $20.35 +241.47% +111.19% +130.28 1 Comment
poang 28.86 9/15/2006 Outperform 3Y $20.47 +239.56% +111.69% +127.87 0 Comment
predfern 48.28 9/15/2006 Outperform 5Y $20.47 +239.56% +111.69% +127.87 1 Comment
shanedawg 77.64 9/16/2006 Outperform 1Y $20.50 +239.06% +111.21% +127.85 0 Comment
nepedal < 20 9/21/2006 Outperform 3Y $20.55 +238.15% +111.66% +126.49 1 Comment
MYSTICQUEEN 73.26 9/21/2006 Outperform 3Y $20.62 +237.08% +111.67% +125.42 0 Comment
pharmaway < 20 9/14/2006 5/6/2008 Outperform 1Y $20.55 +238.15% +113.85% +124.30 1 Comment
jolen168 < 20 9/14/2006 Outperform 3Y $20.59 +237.58% +113.38% +124.20 0 Comment
littleboyblue2 68.91 9/14/2006 Outperform 3M $20.59 +237.58% +113.38% +124.20 0 Comment
bronxboston 24.66 9/14/2006 Outperform 1Y $20.59 +237.58% +113.38% +124.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
Anonymous331 35.59 6/18/2018 Outperform 5Y $77.21 -10.00% -4.38% -5.61 0 Comment
Anonymous331 35.59 1/14/2016 Outperform 5Y $103.50 +13.28% +12.24% +1.03 11/9/2016 @ $117.24 0 Comment
TrackPiperJaff 87.26 4/25/2014 Outperform NS $70.91 -2.00% +41.09% -43.08 0 Comment
TrackGoldmanSach 73.14 1/6/2014 Underperform NS $82.95 -16.22% +43.96% +60.19 0 Comment
TrackCreditSuiss 88.68 12/10/2013 Outperform NS $85.27 -18.50% +45.94% -64.45 0 Comment
TrackUBS 91.92 12/5/2013 Outperform NS $81.54 -14.78% +47.22% -62.00 0 Comment
TrackArgus 89.76 6/13/2013 Outperform NS $59.49 +16.81% +63.39% -46.58 0 Comment
TrackZacks < 20 10/25/2012 Underperform 3M $37.16 +1.32% -2.09% -3.40 11/12/2012 @ $37.65 1 Comment
TrackWayneRogers 58.40 7/27/2012 Outperform 3M $35.30 +96.86% +90.46% +6.40 0 Comment
TrackArgus 89.76 7/2/2012 Outperform NS $32.34 +53.08% +10.01% +43.08 1/28/2013 @ $49.50 0 Comment
TrackCowenandCo 79.89 6/26/2012 Outperform NS $31.00 +124.14% +100.55% +23.59 0 Comment
TrackPoisedTo < 20 5/16/2012 Outperform 5Y $35.62 +95.09% +97.20% -2.11 0 Comment
TrackCantorFitz 35.69 4/4/2012 Outperform NS $40.00 +58.37% +11.45% +46.92 4/22/2013 @ $63.34 0 Comment
trackmizuho < 20 1/10/2012 Outperform NS $34.60 +100.87% +104.13% -3.27 0 Comment
tracksummerstree 92.01 8/17/2011 Outperform NS $28.10 +147.30% +120.66% +26.64 0 Comment
TrackZacks < 20 8/11/2011 Outperform 3M $26.83 +44.18% +17.03% +27.15 4/24/2012 @ $38.68 1 Comment
TrackJimCramer 85.26 11/12/2010 Outperform 3W $30.15 +130.48% +119.75% +10.74 0 Comment
TrackZacks < 20 10/28/2010 Outperform 3M $30.60 -7.78% +7.25% -15.02 1/10/2011 @ $28.22 1 Comment
TrackStifel 91.90 9/9/2010 Outperform NS $27.30 +154.59% +136.57% +18.02 0 Comment
TrackJimCramer 85.26 7/26/2010 Underperform 3W $27.25 +10.66% +7.74% -2.92 11/13/2010 @ $30.15 0 Comment
TrackMorganJos 81.56 7/12/2010 Outperform NS $25.84 +5.81% +20.89% -15.09 1/28/2011 @ $27.34 0 Comment
TrackJefferies 83.42 6/7/2010 Outperform NS $27.12 +156.23% +146.39% +9.84 0 Comment
TrackSoleil 94.71 12/3/2009 Outperform NS $28.75 +141.70% +136.78% +4.92 0 Comment
TrackRWBaird 87.05 9/22/2009 Outperform NS $26.77 +49.90% +37.81% +12.08 10/5/2012 @ $40.12 0 Comment
TrackCowenandCo 79.89 8/6/2009 Underperform NS $27.75 +13.08% +30.76% +17.68 6/26/2012 @ $31.38 0 Comment
trackmerriman 69.68 7/28/2009 Outperform NS $27.28 +154.73% +171.74% -17.01 0 Comment
TrackDeutscheSec 85.00 7/22/2009 Outperform NS $23.80 +192.04% +179.44% +12.60 0 Comment
TrackMorganJos 81.56 6/16/2009 Outperform NS $21.30 +30.99% +4.62% +26.37 7/24/2009 @ $27.90 0 Comment
TrackWedbush 87.25 3/20/2009 Outperform NS $22.99 +202.27% +244.23% -41.96 0 Comment
TrackOppenheimer 64.22 2/18/2009 Outperform NS $26.19 +165.33% +236.87% -71.54 0 Comment
TrackRBCCapMkts 84.83 2/4/2009 Outperform NS $26.59 -1.94% +55.42% -57.36 2/24/2011 @ $26.08 0 Comment
TrackZacks < 20 2/2/2009 Outperform 3M $26.74 -20.87% +1.24% -22.11 4/6/2009 @ $21.16 1 Comment
TrackBarclaysCap 88.76 1/7/2009 Outperform NS $25.71 +170.34% +193.05% -22.71 0 Comment
TrackRWBaird 87.05 10/13/2008 Outperform NS $28.33 -4.61% -0.79% -3.81 1/6/2009 @ $27.03 0 Comment
TrackBWS 97.09 10/10/2008 Outperform NS $26.72 +93.24% +73.44% +19.80 3/1/2013 @ $51.63 0 Comment
TrackCowenandCo 79.89 10/8/2008 Outperform NS $27.35 +1.48% +3.40% -1.92 8/6/2009 @ $27.75 0 Comment
TrackCreditSuiss 88.68 7/25/2008 Outperform NS $37.23 -43.79% -30.88% -12.91 5/1/2009 @ $20.93 0 Comment
TrackPacificGrow < 20 5/9/2008 Outperform NS $30.63 +27.83% -0.71% +28.54 4/17/2012 @ $39.16 0 Comment
TrackWellsFargo 88.29 12/4/2007 Outperform NS $30.06 +131.17% +88.68% +42.49 0 Comment
TrackBofASec 92.05 11/26/2007 Outperform NS $31.60 +119.91% +91.60% +28.30 0 Comment
TrackBMOCapital < 20 11/20/2007 Outperform NS $32.44 +114.24% +92.03% +22.21 0 Comment
TrackSwensen < 20 9/30/2007 Outperform NS $35.66 +94.90% +81.37% +13.52 1 Comment
TrackWMBlair 77.38 8/28/2007 Outperform NS $30.00 +131.63% +91.51% +40.12 0 Comment
TrackCowenandCo 79.89 8/8/2007 Outperform NS $30.92 -17.85% +1.70% -19.55 12/12/2007 @ $25.40 0 Comment
TrackJefferies 83.42 7/12/2007 Outperform NS $30.00 +3.45% -22.01% +25.46 4/9/2010 @ $31.04 0 Comment
TrackLehmanBros < 20 6/26/2007 Outperform NS $28.63 +36.76% -8.08% +44.84 4/17/2012 @ $39.16 0 Comment
TrackCreditSuiss 88.68 5/11/2007 Outperform NS $31.66 -3.68% -7.34% +3.66 5/9/2008 @ $30.50 0 Comment
TrackPiperJaff 87.26 4/5/2007 Outperform NS $28.04 +39.20% +0.18% +39.02 10/11/2012 @ $39.03 0 Comment
TrackBernstein 90.54 3/13/2007 Outperform NS $25.69 +170.55% +99.45% +71.09 0 Comment
TrackUBS 91.92 2/21/2007 Outperform NS $26.85 +36.79% -1.21% +37.99 9/10/2012 @ $36.73 0 Comment
TrackRodmanRen < 20 12/18/2006 Outperform NS $29.38 +136.56% +96.68% +39.88 0 Comment
TrackFBRCapitalM 85.61 12/11/2006 Outperform NS $28.35 +12.67% -9.70% +22.37 6/30/2008 @ $31.94 0 Comment
TrackLazardCapit 75.81 11/20/2006 Outperform NS $28.10 +147.30% +100.15% +47.15 0 Comment
TrackJMP 83.06 10/30/2006 Outperform NS $24.30 +186.03% +103.73% +82.29 0 Comment
TrackJimCramer 85.26 2/27/2006 Outperform 3W $19.23 +41.72% -14.10% +55.82 7/26/2010 @ $27.25 0 Comment

Advertisement